About The Study: In this population-based cohort, 1-year mortality after an emergency department visit for an opioid overdose was 8.6%, and 21.2% of individuals experienced a repeat opioid overdose. Mortality was higher than estimates from previous research conducted prior to the widespread availability of fentanyl (5.3%-5.5%), although differences in cohort definitions may contribute.

About The Study: In this randomized clinical trial, psilocybin appeared to be safe and efficacious for treating cocaine use disorder among individuals from underrepresented and vulnerable populations. Further research is warranted to replicate and expand these findings.

The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseq^TM, a clinical whole-genome sequencing (WGS) test specifically for multiple myeloma. Approximately 35,000 new cases of multiple myeloma are diagnosed annually in the U.S., making it the second-most common blood cancer. The JAYseq test, developed and performed by TGen Clinical Laboratory, a CAP‑accredited lab founded by TGen, is intended for patients with newly diagnosed multiple myeloma, relapsed or refractory disease, or related plasma cell disorders.

Being around trees is proven to enhance health, from lowering stress to increasing longevity. However, a new national study led by Michigan State University researcher Amber Pearson reveals a surprise: The biological benefits of nature are not experienced equally across all populations.

An early estimate of COVID-19 vaccine effectiveness for the 2025/26 season in Canada found that the vaccine had a protective effect even in the context of mismatched lineages.

A study presented at the ESMO Breast Cancer 2026 congress examines whether an efficiently delivered genetic testing can identify gPV carriers among previously untested patients, enabling prevention, earlier screening, and family risk assessment, while supporting a sustainable healthcare delivery model.